Perylenequinones in photodynamic therapy: Cellular versus vascular response

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 25, Issue 1-2, 2006, Pages 223-237

  Olivo, Malini ^a   Chin, W L William ^b  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Anticellular; Antivascular; Drug light interval; Hypericin; Hypocrellins; Perylenequinone; Photodynamic therapy

Indexed keywords

HYPERICIN; HYPOCRELLIN A; HYPOCRELLIN B; PHOTOSENSITIZING AGENT; QUINONE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER THERAPY; CELL ACTIVITY; CELL DEATH; CHORIOALLANTOIS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; DRUG TARGETING; EXPERIMENTAL MODEL; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; XENOGRAFT;

ANIMALIA;

EID: 33644748399     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.140     Document Type: Article

References (41)

1. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q. Photodynamic therapy. J Natl Cancer Inst 1998; 90(12):889-905.
2. Brown SB, Brown EA, Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol 2004; 5(8):497-508.
3. Vicente MG. Porphyrin-based sensitizers in the detection and treatment of cancer: recent progress. Curr Med Chem Anti-Canc Agents 2001; 1(2):175-194.
4. Kubin A, Alth G, Jindra R, Jessner G, Ebermann R. Wavelength-dependent photoresponse of biological and aqueous model systems using the photodynamic plant pigment hypericin. J Photochem Photobiol B 1996; 36(2):103-108.
5. Schempp CM, Simon-Haarhaus B, Heine A, Schopf E, Simon JC. In vitro and in vivo activation of hypericin with the incoherent light source PDT 1200 SOA (520-750 nm) and with solar simulated radiation (290-2500 nm). Photodermatol Photoimmunol Photomed 1999; 15(1):13-17.
6. Miller GG, Brown K, Moore RB, Diwu ZJ, Liu J, Huang L, Lown JW, Begg DA, Chlumecky V, Tulip J, et al. Uptake kinetics and intracellular localization of hypocrellin photosensitizers for photodynamic therapy: a confocal microscopy study. Photochem Photobiol 1995; 61(6):632-638.
7. Hopfner M, Maaser K, Theiss A, Lenz M, Sutter AP, Kashtan H, von Lampe B, Riecken EO, Zeitz M, Scherubl H. Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells. Int J Colorectal Dis 2003; 18(3):239-247.
8. Diwu Z. Novel therapeutic and diagnostic applications of hypocrellins and hypericins. Photochem Photobiol 1995; 61(6):529-539.
9. Diwu Z, Zimmermann J, Meyer T, Lown JW. Design, synthesis and investigation of mechanisms of action of novel protein kinase C inhibitors: perylenequinonoid pigments. Biochem Pharmacol 1994; 47(2):373-385.
10. Ali SM, Olivo M. Mechanisms of action of phenanthroperylenequinones in photodynamic therapy (review). Int J Oncol 2003; 22(6):1181-1191.
11. Du HY, Olivo M, Tan BK, Bay BH. Hypericin-mediated photodynamic therapy induces lipid peroxidation and necrosis in nasopharyngeal cancer. Int J Oncol 2003; 23(5):1401-1405.
12. Diwu Z, Lown JW. Photosensitization with anticancer agents 14. Perylenequinonoid pigments as new potential photodynamic therapeutic agents: formation of tautomeric semiquinone radicals. J Photochem Photobiol A: Chem 1992; 69:191-199.
13. Diwu Z, Lown JW. Photosensitization with anticancer agents. 15. Perylenequinonoid pigments as potential photodynamic therapeutic agents: formation of semiquinone radicals and reactive oxygen species on illumination. J Photochem Photobiol B 1993; 18(2-3):131-143.
14. Ali SM, Olivo M. Bio-distribution and subcellular localization of Hypericin and its role in PDT induced apoptosis in cancer cells. Int J Oncol 2002; 21(3):531-540.
15. Ali SM, Olivo M. Efficacy of hypocrellin pharmacokinetics in phototherapy. Int J Oncol 2002; 21(6):1229-1237.
16. Ali SM, Olivo M, Yuen GY, Chee SK. Photodynamic-induced apoptosis of human nasopharyngeal carcinoma cells using Hypocrellins. Int J Oncol 2001; 19(3):633-643.
17. Ali SM, Olivo M. Nitric oxide mediated photo-induced cell death in human malignant cells. Int J Oncol 2003; 22(4):751-756.
18. Ali SM, Chee SK, Yuen GY, Olivo M. Hypocrellins and Hypericin induced apoptosis in human tumor cells: A possible role of hydrogen peroxide. Int J Mol Med 2002; 9(5):461-472.
19. Ali SM, Chee SK, Yuen GY, Olivo M. Hypericin induced death receptor-mediated apoptosis in photoactivated tumor cells. Int J Mol Med 2002; 9(6):601-616.
20. Ali SM, Chee SK, Yuen GY, Olivo M. Photodynamic therapy induced Fas-mediated apoptosis in human carcinoma cells. Int J Mol Med 2002; 9(3):257-270.
21. Ali SM, Olivo M, Yuen GY, Chee SK. Induction of apoptosis by hypericin through activation of caspase-3 in human carcinoma cells. Int J Mol Med 2001; 8(5)521-530.
22. Du HY, Bay BH, Olivo M. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model. Int J Oncol 2003; 22(5):1019-1024.
23. Chin W, Lau W, Cheng C, Olivo M. Evaluation of Hypocrellin B in a human bladder tumor model in experimental photodynamic therapy: Biodistribution, light dose and drug-light interval effects. Int J Oncol 2004; 25(3):623-629.
24. Chin W, Lau W, Lay SL, Wei KK, Olivo M. Photodynamic-induced vascular damage of the chick chorioallantoic membrane model using perylenequinones. Int J Oncol 2004; 25(4):887-891.
25. Piette J, Volanti C, Vantieghem A, Matroule JY, Habraken Y, Agostinis P. Cell death and growth arrest in response to photodynamic therapy with membrane-bound photosensitizers. Biochem Pharmacol 2003; 66(8):1651-1659.
26. Wang ZJ, He YY, Huang CG, Huang JS, Huang YC, An JY, Gu Y, Jiang LJ. Pharmacokinetics, tissue distribution and photodynamic therapy efficacy of liposomal-delivered hypocrellin A, a potential photosensitizer for tumor therapy. Photochem Photobiol 1999; 70(5):773-780.
27. Abels C. Targeting of the vascular system of solid tumours by photodynamic therapy (PDT). Photochem Photobiol Sci 2004; 3(8):765-771.
28. Chen B, Roskams T, de Witte PA. Antivascular tumor eradication by hypericin-mediated photodynamic therapy. Photochem Photobiol 2002; 76(5):509-513.
29. Chen B, Roskams T, Xu Y, Agostinis P, de Witte PA. Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model. Int J Cancer 2002; 98(2):284-290.
30. Luksiene Z, de Witte PA. Hypericin as novel and promising photodynamic therapy tool: studies on intracellular accumulation capacity and growth inhibition efficiency. Medicina (Kaunas) 2003; 39(7):677-682.
31. Kurohane K, Tominaga A, Sato K, North JR, Namba Y, Oku N. Photodynamic therapy targeted to tumor-induced angiogenic vessels. Cancer Lett 2001; 167(1):49-56.
32. Dolmans DE, Fukumura D, Jain RK. TIMELINE: Photodynamic therapy for cancer. Nat Rev Cancer 2003; 3(5):380-387.
33. Zilberstein J, Schreiber S, Bloemers MC, Bendel P, Neeman M, Schechtman E, Kohen F, Scherz A, Salomon Y. Antivascular treatment of solid melanoma tumors with bacteriochlorophyll-serine-based photodynamic therapy. Photochem Photobiol 2001; 73(3):257-266.
34. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407(6801):242-248.
35. Uehara M, Inokuchi T, Sano K, ZuoLin W. Expression of vascular endothelial growth factor in mouse tumours subjected to photodynamic therapy. Eur J Cancer 2001; 37(16):2111-2115.
36. Tsutsui H, MacRobert AJ, Curnow A, Rogowska A, Buonaccorsi G, Kato H, Bown SG. Optimisation of illumination for photodynamic therapy with mTHPC on normal colon and a transplantable tumour in rats. Lasers Med Sci 2002; 17(2):101-109.
37. Zhou Q, Olivo M, Lye KY, Moore S, Sharma A, Chowbay B. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models. Cancer Chemother Pharmacol 2005 (in press).
38. Pytel A, Schmeller N. New aspect of photodynamic diagnosis of bladder tumors: fluorescence cytology. Urology 2002; 59(2):216-219.
39. D'Hallewin MA, De Witte PA, Waelkens E, Merlevede W, Baert L. Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin. J Urol 2000; 164:349-351.
40. Olivo M, Lau W, Manivasager V, Tan PH, Soo KC, Cheng C. Macro-microscopic fluorescence of human bladder cancer using hypericin fluorescence cystoscopy and laser confocal microscopy. Int J Oncol 2003; 23(4):983-990.
41. Kamuhabwa A, Agostinis P, Ahmed B, Landuyt W, Van Cleynenbreugel B, Van Poppel H, De Witte P. Hypericin as a potential phototherapeutic agent in superficial transitional cell carcinoma of the bladder. Photochem Photobiol Sci 2004; 3(8):772-780.